Comment on Maddaloni et al. Bone-Vascular Axis Biomarkers: Enhancing Cardiovascular Risk Management in Type 2 Diabetes.
作者信息
Zhao Kun, Wu Lingling, Guo Meixiang
机构信息
Shanghai Jiao Tong University Affiliated Sixth People's Hospital South Campus, Shanghai, China.
Shanghai Fengxian District Central Hospital, Shanghai, China.
出版信息
Diabetes Care. 2025 Apr 1;48(4):e60. doi: 10.2337/dc24-2720.
Abstract
摘要
相似文献
1
Comment on Maddaloni et al. Bone-Vascular Axis Biomarkers: Enhancing Cardiovascular Risk Management in Type 2 Diabetes.
Diabetes Care. 2025 Apr 1;48(4):e60. doi: 10.2337/dc24-2720.
2
Comment on Maddaloni et al. Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. Diabetes Care 2025;48:235-242.
Diabetes Care. 2025 Apr 1;48(4):e58-e59. doi: 10.2337/dc24-2705.
3
Response to Comments on Maddaloni et al. Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. Diabetes Care 2025;48:235-242.
Diabetes Care. 2025 Apr 1;48(4):e61-e62. doi: 10.2337/dci24-0109.
4
Comment on Podmore et al. Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes: The EPIC-InterAct Study. Diabetes Care 2016;39:572-581.
Diabetes Care. 2016 Sep;39(9):e149-50. doi: 10.2337/dc16-0538.
5
Comment on Sharif et al. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes. Diabetes Care 2016;39:1424-1430.
Diabetes Care. 2016 Oct;39(10):e189. doi: 10.2337/dc16-1211.
6
Response to Comment on Sharif et al. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes. Diabetes Care 2016;39:1424-1430.
Diabetes Care. 2016 Oct;39(10):e190-1. doi: 10.2337/dci16-0023.
7
Comment on Garofolo et al. Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study. Diabetes Care 2020;43:e139-e141.
Diabetes Care. 2021 Apr;44(4):e79-e80. doi: 10.2337/dc20-2934.
8
Response to Comment on Lee et al. Diabetes 2015;64:2836-2846. Comment on Roberts et al. Diabetes 2015;64:471-484.
Diabetes. 2016 Mar;65(3):e17. doi: 10.2337/dbi15-0030.
9
Lifestyle Management of Diabetes: Implications for the Bone-Vascular Axis.
Curr Diab Rep. 2018 Aug 18;18(10):84. doi: 10.1007/s11892-018-1060-y.
10
Comment on Lee et al. Diabetes 2015;64:2836-2846. Comment on Roberts et al. Diabetes 2015;64:471-484.
Diabetes. 2016 Mar;65(3):e15. doi: 10.2337/db15-1176.
本文引用的文献
1
Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL.
Diabetes Care. 2025 Feb 1;48(2):235-242. doi: 10.2337/dc24-1455.
2
Association and Interaction of Genetics and Area-Level Socioeconomic Factors on the Prevalence of Type 2 Diabetes and Obesity.
Diabetes Care. 2023 May 1;46(5):944-952. doi: 10.2337/dc22-1954.
3
Sleep Duration and Risks of Incident Cardiovascular Disease and Mortality Among People With Type 2 Diabetes.
Diabetes Care. 2023 Jan 1;46(1):101-110. doi: 10.2337/dc22-1127.
4
Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study.
Lancet Diabetes Endocrinol. 2019 Sep;7(9):684-694. doi: 10.1016/S2213-8587(19)30187-1. Epub 2019 Jul 22.
5
The impact of diabetes and diabetes medications on bone health.
Endocr Rev. 2015 Apr;36(2):194-213. doi: 10.1210/er.2012-1042. Epub 2015 Mar 4.
Zotero 插件